Posters & publications

You are here

Novosanis received a grant from Interreg CrossCare to build a next-generation of its unique and patented intradermal drug delivery device, VAX-ID , in collaboration with living labs Happy Aging (Belgium) and CIC (the Netherlands).
Novosanis is developing the VAX-ID platform suited for accurate drug delivery of e.g. vaccines in the dermal layer of the skin.
Assessment of skin thickness in healthy adult volunteers
Comparison of IM and ID injection of HepB vaccine

Pages